勒梅特微管医疗 LMAT 深 沪
等待开盘 08-05 09:30:00 美东时间
84.36
+3.320
+4.10%
华盛通- 最 高84.47
- 今 开81.49
- 成交量 15.47万股
- 最 低 81.49
- 昨 收 81.04
- 总市值 19.06亿
- 52周最高 109.18
- 市盈率 静 43.64
- 换手率 0.68%
- 52周最低 71.22
- 委 比 -6.83%
- 总股本 2259.44万
- 历史最高 109.18
- 量 比 1.55
- 振 幅 3.68%
- 历史最低 0.595
- 每 手 1
- 风险率 7.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
今天 16:32
Barrington Research Reiterates Market Perform on LeMaitre Vascularto Market Perform
Barrington Research analyst Michael Petusky reiterates LeMaitre Vascular (NASDAQ:LMAT) from Market Perform to Market Perform.
07-22 22:27
LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025
LeMaitre Vascular, Inc. announced the release of its second quarter 2025 financial results on August 5, 2025, after market close, followed by a conference call at 5:00 PM EDT to discuss the results, business highlights, and company outlook. Interested parties can register online for the call and access the audio webcast at ir.lemaitre.com. LeMaitre is a leading provider of devices and services for treating peripheral vascular disease.
07-08 20:04
Elutia Inc. Ends Distribution Agreement with LeMaitre
An update from Aziyo Biologics ( ($ELUT) ) is now available. On April 30, 2025,...
05-07 05:15
Earnings Scheduled For May 1, 2025
Companies Reporting Before The Bell • Itron (NASDAQ:ITRI) is projected to repor...
05-01 16:32
NovoCure's Earnings: A Preview
NovoCure (NASDAQ:NVCR) is gearing up to announce its quarterly earnings on Thur...
04-24 04:03
MYHOTELMATCH General Assembly Approves Key Resolutions
MyHotelMatch ( ($FR:MHM) ) has shared an announcement. The Ordinary General Ass...
03-26 07:21
美股大行评级 | CJS Securities：上调艾伦建材评级至"跑赢大市"，目标价110美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1102515815739830272.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Denali Therapeutics(DNLI)"买入"评级，目标价从80美元升至87美元</p> <p>• HC Wainwright & Co.：维持Car
03-01 09:21
LeMaitre cut to perform by Oppenheimer on valuation
Oppenheimer has downgraded LeMaitre Vascular (NASDAQ:LMAT) to perform from outperform as its price target of $93 has been met. The investment bank added it was downgrading the stock and removing its ...
02-28 23:54
Barrington Research Downgrades LeMaitre Vascular to Market Perform
Barrington Research analyst Michael Petusky downgrades LeMaitre Vascular (NASDAQ:LMAT) from Outperform to Market Perform.
02-28 20:43
